Effectiveness of a multifaceted intervention for potentially inappropriate prescribing in older patients in primary care: A cluster-randomized controlled trial (OPTI-SCRIPT study)

Annals of Family Medicine

Volumn 13, Issue 6, 2015, Pages 545-553

  Clyne, Barbara ^a   Smith, Susan M ^a   Hughes, Carmel M ^b   Boland, Fiona ^a   Bradley, Marie C ^c   Cooper, Janine A ^a,b   Fahey, Tom ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Potentially inappropriate; Practice based; Prescribing; Prescription drugs; Primary health care; Randomized controlled trial; Research

Indexed keywords

PROTON PUMP INHIBITOR;

AGED; ALGORITHM; CLINICAL PRACTICE; CLINICAL TRIAL; CLUSTER ANALYSIS; COMPUTER ASSISTED DRUG THERAPY; CONTROLLED STUDY; FEMALE; HEALTH CARE DELIVERY; HUMAN; INAPPROPRIATE PRESCRIBING; IRELAND; MALE; MULTICENTER STUDY; PREVENTION AND CONTROL; PRIMARY HEALTH CARE; PROCEDURES; PROGRAM EVALUATION; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; STATISTICS AND NUMERICAL DATA;

AGED; ALGORITHMS; CLUSTER ANALYSIS; DELIVERY OF HEALTH CARE; DRUG THERAPY, COMPUTER-ASSISTED; FEMALE; HUMANS; INAPPROPRIATE PRESCRIBING; IRELAND; MALE; PRACTICE PATTERNS, PHYSICIANS'; PRIMARY HEALTH CARE; PROGRAM EVALUATION; PROTON PUMP INHIBITORS; REGRESSION ANALYSIS;

EID: 84946911003     PISSN: 15441709     EISSN: 15441717     Source Type: Journal    
DOI: 10.1370/afm.1838     Document Type: Article

References (42)

1. Milton JC, Hill-Smith I, Jackson SH. Prescribing for older people. BMJ. 2008;336(7644):606-609.
2. Spinewine A, Schmader KE, Barber N, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet. 2007;370(9582):173-184.
3. Kaufmann CP, Tremp R, Hersberger KE, Lampert ML. Inappropriate prescribing: a systematic overview of published assessment tools. Eur J Clin Pharmacol. 2014;70(1):1-11.
4. O’Mahony D, Gallagher PF. Inappropriate prescribing in the older population: need for new criteria. Age Ageing. 2008;37(2):138-141.
5. Jano E, Aparasu RR. Healthcare outcomes associated with Beers’ criteria: a systematic review. Ann Pharmacother. 2007;41(3):438-447.
6. Hamilton HJ, Gallagher PF, O’Mahony D. Inappropriate prescribing and adverse drug events in older people. BMC Geriatr. 2009;9:5.
7. Cahir C, Fahey T, Teeling M, Teljeur C, Feely J, Bennett K. Potentially inappropriate prescribing and cost outcomes for older people: a national population study. Br J Clin Pharmacol. 2010;69(5):543-552.
8. Cahir C, Bennett K, Teljeur C, Fahey T. Potentially inappropriate prescribing and adverse health outcomes in community dwelling older patients. Br J Clin Pharmacol. 2014;77(1):201-210.
9. Marcum ZA, Handler SM, Wright R, Hanlon JT. Interventions to improve suboptimal prescribing in nursing homes: A narrative review. Am J Geriatr Pharmacother. 2010;8(3):183-200.
10. Garcia RM. Five ways you can reduce inappropriate prescribing in the elderly: a systematic review. J Fam Pract. 2006;55(4):305-312.
11. Majumdar SR, Soumerai SB. Why most interventions to improve physician prescribing do not seem to work. CMAJ. 2003;169(1):30-31.
12. Grimshaw JM, Shirran L, Thomas R, et al. Changing provider behavior: an overview of systematic reviews of interventions. Med Care. 2001;39(8):(8 Suppl 2):II2-45.
13. Bregnhoj L, Thirstrup S, Kristensen MB, Bjerrum L, Sonne J. Combined intervention programme reduces inappropriate prescribing in elderly patients exposed to polypharmacy in primary care. Eur J Clin Pharmacol. 2009;65(2):199-207.
14. Rognstad S, Brekke M, Fetveit A, Dalen I, Straand J. Prescription peer academic detailing to reduce inappropriate prescribing for older patients: a cluster randomised controlled trial. Br J Gen Pract. 2013;63(613):e554-e562.
15. Campbell MK, Elbourne DR, Altman DG; CONSORT group. CONSORT statement: extension to cluster randomised trials. BMJ. 2004;328(7441):702-708.
16. Clyne B, Bradley MC, Hughes CM, et al; OPTI-SCRIPT study team. Addressing potentially inappropriate prescribing in older patients: development and pilot study of an intervention in primary care (the OPTI-SCRIPT study). BMC Health Serv Res. 2013;13(1):307.
17. Clyne B, Bradley MC, Smith SM, et al; OPTI-SCRIPT Study Team. Effectiveness of medicines review with web-based pharmaceutical treatment algorithms in reducing potentially inappropriate prescribing in older people in primary care: a cluster randomized trial (OPTI-SCRIPT study protocol). Trials. 2013;14(1):72.
18. Saghaei M. An overview of randomization and minimization programs for randomized clinical trials. J Med Signals Sens. 2011;1(1): 55-61.
19. Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14(1):1-24.
20. Pouwer F, van der Ploeg HM, Ader HJ, Heine RJ, Snoek FJ. The 12-item well-being questionnaire. An evaluation of its validity and reliability in Dutch people with diabetes. Diabetes Care. 1999;22(12):2004-2010.
21. Soumerai SB, McLaughlin TJ, Avorn J. Improving drug prescribing in primary care: a critical analysis of the experimental literature. Milbank Q. 1989;67(2):268-317.
22. Jamtvedt G, Young JM, Kristoffersen DT, O’Brien MA, Oxman AD. Audit and feedback: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2006;(2):CD000259.
23. Hysong SJ. Meta-analysis: audit and feedback features impact effectiveness on care quality. Med Care. 2009;47(3):356-363.
24. Health Service Executive. Primary Care Reimbursement Service Statistical Analysis of Claims and Payments 2011. Dublin, Ireland: Health Service Executive; 2011.
25. Alldred DP, Raynor DK, Hughes C, Barber N, Chen TF, Spoor P. Interventions to optimise prescribing for older people in care homes. Cochrane Database Syst Rev. 2013;2(2):CD009095.
26. Forsetlund L, Eike MC, Gjerberg E, Vist GE. Effect of interventions to reduce potentially inappropriate use of drugs in nursing homes: a systematic review of randomised controlled trials. BMC Geriatr. 2011;11(1):16.
27. Yourman L, Concato J, Agostini JV. Use of computer decision support interventions to improve medication prescribing in older adults: a systematic review. Am J Geriatr Pharmacother. 2008;6(2):119-129.
28. Kaur S, Mitchell G, Vitetta L, Roberts MS. Interventions that can reduce inappropriate prescribing in the elderly: a systematic review. Drugs Aging. 2009;26(12):1013-1028.
29. Straand J, Fetveit A, Rognstad S, Gjelstad S, Brekke M, Dalen I. A cluster-randomized educational intervention to reduce inappropriate prescription patterns for elderly patients in general practice-The Prescription Peer Academic Detailing (Rx-PAD) study [NCT00281450]. BMC Health Serv Res. 2006;6(1):72.
30. Raebel MA, Charles J, Dugan J, et al. Randomized trial to improve prescribing safety in ambulatory elderly patients. J Am Geriatr Soc. 2007;55(7):977-985.
31. Smith AJ, Tett SE. Improving the use of benzodiazepines-is it possible? A non-systematic review of interventions tried in the last 20 years. BMC Health Serv Res. 2010;10:321.
32. Cook JM, Marshall R, Masci C, Coyne JC. Physicians’ perspectives on prescribing benzodiazepines for older adults: a qualitative study. J Gen Intern Med. 2007;22(3):303-307.
33. Iliffe S, Curran HV, Collins R, Yuen Kee SC, Fletcher S, Woods B. Attitudes to long-term use of benzodiazepine hypnotics by older people in general practice: findings from interviews with service users and providers. Aging Ment Health. 2004;8(3):242-248.
34. Porteous T, Francis J, Bond C, Hannaford P. Temporal stability of beliefs about medicines: implications for optimising adherence. Patient Educ Couns. 2010;79(2):225-230.
35. Zhang J, Yu KF. What’s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280 (19):1690-1691.
36. Jones R, Jones RO, McCowan C, Montgomery AA, Fahey T. The external validity of published randomized controlled trials in primary care. BMC Fam Pract. 2009;10(1):5.
37. O’Dowd T, O’Kelly M, O’Kelly F. Structure of General Practice in Ireland 1982-2005. Dublin, Ireland: Trinity College Dublin; 2006.
38. Patterson SM, Hughes C, Kerse N, Cardwell C, Bradley MC. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Sys Rev. 2012;5:CD008165.
39. Scott IA, Gray LC, Martin JH, Pillans PI, Mitchell CA. Deciding when to stop: towards evidence-based deprescribing of drugs in older populations. Evid Based Med. 2013;18(4):121-124.
40. Yang YX, Lewis JD, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA. 2006;296(24): 2947-2953.
41. Laheij RJ, Sturkenboom MC, Hassing RJ, Dieleman J, Stricker BH, Jansen JB. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA. 2004;292(16):1955-1960.
42. Cahir C, Fahey T, Tilson L, Teljeur C, Bennett K. Proton pump inhibitors: potential cost reductions by applying prescribing guidelines. BMC Health Serv Res. 2012;12(1):408.